CLASS II Device recall · Reported 18 Aug 2021 · FDA Enforcement Report

FilmArray Blood Culture Identification recalled by BioFire Diagnostics

BioFire Diagnostics is recalling FilmArray Blood Culture Identification (Bcid) Panel Product Pouch Label: FilmArray Bcid, distributed nationwide in the US. The recall was initiated on 20 Jul 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart No: RFIT-ASY-0126 / UDI: 00815381020086; Part No: RFIT-ASY-0127 / UDI: 00815381020093; Kit Lot# 0868221; Pouch Lot# 194Z21; Batch 003
Quantity recalled29 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2245-2021
FDA event ID
88410
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Terminated
Recall initiated
20 Jul 2021
FDA classified
11 Aug 2021
Reported
18 Aug 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Jul 2021Recall initiated by company
11 Aug 2021Classified by FDA+22 days
18 Aug 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to product complaints received for false negative results (dropouts) with blood culture identification panel potential caused by a pouch manufacturing error.

Product as listed by the FDA

FilmArray Blood Culture Identification (BCID) Panel Product Pouch Label: FilmArray BCID Panel Part No: RFIT-ASY-0126 Part No: RFIT-ASY-0127

Where it was distributed

U.S. Nationwide Distribution in the states of : FL, MI, NJ, OH, VA and WI. O.U.S.: None

Nationwide FloridaMichiganNew JerseyOhioVirginiaWisconsin

Questions about this recall

Is FilmArray Blood Culture Identification (Bcid) Panel Product Pouch Label: FilmArray Bcid recalled?

Yes. BioFire Diagnostics recalled FilmArray Blood Culture Identification (Bcid) Panel Product Pouch Label: FilmArray Bcid on 20 Jul 2021. The recall is Class II and its status is Terminated. Recall number Z-2245-2021.

Why was it recalled?

Due to product complaints received for false negative results (dropouts) with blood culture identification panel potential caused by a pouch manufacturing error.

Which lots are affected?

Part No: RFIT-ASY-0126 / UDI: 00815381020086; Part No: RFIT-ASY-0127 / UDI: 00815381020093; Kit Lot# 0868221; Pouch Lot# 194Z21; Batch 003

Where was it sold?

U.S. Nationwide Distribution in the states of : FL, MI, NJ, OH, VA and WI. O.U.S.: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other Other Medical Devices recalls

All 13,778